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1.0. Factors limiting exercise capacity  
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Exercise intolerance refers to patient’s inability to undertake physical task at the 
level and/or for the duration that would be expected considering his or her age and 
general functional capacity. When this inability is caused by impaired function of one 
or more of the physiological body systems (i.e.: central hemodynamic, respiratory, 
peripheral muscles) the result is the amplification of the sensations of dyspnea and 
peripheral muscle discomfort that is often initiated by peripheral muscle fatigue [1].  
Dyspnea is typically perceived as the distressing sensation of unsatisfied 
inspiration (i.e.: neuro-mechanical coupling) [2]. The physiological mechanisms that 
intensify dyspnea sensations occur to the imbalance between the central respiratory 
efferent drive and the response of the respiratory muscles.  In chronic lung disease 
patients, breathlessness is amplified during exercise consequently to both deteriorating 
ventilatory mechanics and the increased ventilatory demand. 
Peripheral muscle fatigue, associated with the subjective feeling of lower limb 
discomfort, is demonstrated by a decrease in muscle force output and it is due to a 
limited oxygen supply to, and/or utilization of oxygen by, the mitochondria [3]. In 
support of this statement exercise-induced quadriceps muscle fatigue in COPD 
negatively correlates with peak oxygen uptake [4]. Accordingly, cellular oxygen could 
either exceed the normal capacity for maximal oxygen transfer of the oxygen transport 
chain, (i.e.: this is when maximal oxygen uptake has been truly achieved), or stresses 
an impaired physiological system preventing the achievement of a true maximal oxygen 
uptake (i.e.: achieving, as in COPD, peak but not true normal maximal oxygen uptake) 
[5]. In the latter case, a series of failures at the level of respiratory and cardiovascular 
systems may impair the normal peripheral muscle oxygen delivery and conductance 
capabilities [3, 6]. Hence, the factors that restrict exercise capacity in healthy 
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individuals (the former case) are different to that constraining exercise capacity in 
patients with respiratory diseases (the latter case).  
 
1.1. Exercise testing in lung diseases 
To evaluate exercise intolerance, cardiopulmonary exercise testing (CPET) is 
considered the gold standard as it allows simultaneous assessment of objective (i.e.: 
cardiopulmonary responses, operational lung volumes, etc.) and subjective variables 
(intensity of dyspnea and leg discomfort sensations). There are two exercise protocols 
performed either on the treadmill or the cycle ergometer that are commonly used: the 
incremental test to the limit of tolerance and the constant-load test.  
The incremental test to the limit of tolerance induces a smooth gradational stress 
of all  physiological systems during exercise with progressively increased intensity to 
volitional termination.  The incremental test to the limit of tolerance facilitates both 
determination of several physiological responses at the point of exercise limitation (i.e.: 
peak oxygen uptake) and the evaluation of trending phenomena as the severity of 
exercise advances from sub-maximal to maximal tolerable levels. Such trends may, for 
example, refer to the increase in minute ventilation relative to oxygen uptake ( V O2) or 
to carbon dioxide production   ( V CO2), indicating “ventilatory efficiency”. Also, the 
rate of change in V CO2 relative to the change in V O2 is commonly used to non-
invasively identify the “anaerobic threshold”. Similarly, when exercise in undertaken 
on the bicycle ergometer, the rate of change in V O2 relative to work rate is taken to 
reflect “aerobic work efficiency” (Figure 1) [7].   
During constant load exercise the work rate is fixed at a constant fraction of the 
pre-determined maximal or peak work rate (typically 50-80%) and individuals are 
required to exercise for as long as they can tolerate the externally imposed workload. 
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The time to the limit of tolerance is recorded. During these tests, a steady-state response 
(where the energy demands of the working muscles are met by the energy supply 
mechanisms) may or may not be achieved depending on the work intensity and the 
disability level of the individual. Nevertheless, even if a steady-state in the cardio-
respiratory response is to be achieved, this will not occur instantaneously but it will 
happen over a period of time. Hence, the time of dynamic regulation in cardio-
respiratory and metabolic physiological responses provides useful information of the 
dynamic conduct of the respiratory and cardio-respiratory function and of the capacity 
of the cardiorespiratory and metabolic systems to reach a steady-state of oxygen 
utilization [1, 5]. 
Besides the aforementioned incremental and constant load cardiopulmonary 
exercise tests that provide plethora of information on physiological responses, there are 
exercise tests that yield less physiological information, but still provide a measure of 
exercise capacity. The most common ones are the 6-minute walking test [8], and the 
incremental and endurance shuttle walking tests [9, 10], which provide an indication of 
exercise intolerance, the intensity of breathlessness and leg dicomfort, and the degree 
arterial oxygen desaturation.  The 6-min walking test is of sub-maximal intensity and 
is commonly used to determine the effects of various pharmaceutical and non-
pharmaceutical interventions on patients’ exercise capacity [11, 12]. Patients are 
allowed to walk at own pace and encouraged to go around a set of cones positioned on 
the floor as many times as possible. One study [11] indicated that this test yields a 
highly sustainable oxygen uptake, thereby emphasizing the important prognostic value 
of the 6-min walking test. 
During the incremental shuttle walk test [9] the walking speed is progressively 
increased until the point where the patient reaches the limits of his/her tolerance. 
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Accordingly, the incremental shuttle walk test is considered as equivalent to the 
maximal incremental test performed on the treadmill. The intensity of the endurance 
shuttle-walk test corresponds to a fraction of the individual patient’s maximum exercise 
performance assessed by the incremental shuttle walk test. Although the sustained 
intensity is sub-maximal (i.e.: 75 and 85% of intensity) [10] patients commonly reach 
the limits of their tolerance.   
 
1.2. Factors determining exercise tolerance in healthy young 
individuals 
In healthy subjects exercise tolerance refers to the capacity of an individual to 
achieve the maximum attainable amount of work during an exercise protocol where the 
intensity increases progressively until maximum capacity is reached. In this case, 
exercise tolerance is assessed by the maximum capacity of the individual’s body to 
transport and utilize oxygen (i.e.: V O2 max). In turn the achieved V O2 max depends 
on the convective and conductive oxygen delivery and muscle oxygen utilization [3].   
Over the past few decades, a number of studies have been conducted with the 
aim to investigate the limiting factors for achieving V O2max in healthy subjects [13-
15].  A fundamental approach to establish the limiting factors is to compare the 
physiological responses recorded from sedentary and well-trained individuals during 
incremental exercise. Such studies have clearly shown that in healthy sedentary subjects 
compared to highly-trained athletes the main variable that limits V O2max is cardiac 
output [16-19]. In fact, the implemented experimental procedures demonstrated a linear 
relationship between V O2max and maximal cardiac output showing that an average of 
5.0 l/min to 6.0 l/min of cardiac output is needed per liter of V O2 in sedentary subjects, 
whereas in highly-trained subjects cardiac output often reaches 6.0 to 7.0 l/min per liter 
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of V O2. This difference in maximal cardiac output and V O2 between sedentary and 
well-trained subjects was mainly attributed to the lower stroke volume in untrained 
compared to trained individuals [15]. Additionally, the lower hemoglobin concentration 
exhibited by the sedentary individuals has been considered as another contributor to the 
difference in V O2max  [16-19] as this impacts on the arterial oxygen content. 
Experimental reduction in maximal cardiac output and in arterial oxygen content (either 
through the reduction in blood volume or hemoglobin concentration alone) has lead to 
a reduction in systemic oxygen delivery [20-24].   
Besides systemic oxygen delivery, skeletal muscle oxygen extraction as well as 
mitochondrial rate of oxygen consumption has also been shown to differentiate a 
sedentary from a well-trained individual in terms of the potential to achieve a high value 
for V O2max. Specifically, skeletal muscle oxygen extraction limitation could be due to: 
1) limited diffusive conductance for oxygen between the red blood cells and the 
mitochondria; 2) non-uniformity of perfusion in relation to metabolic rate; and/or 3) 
shunting of blood between arterioles and venules, bypassing muscle fibers [1]. The 
limited diffusive conductance for oxygen appears to be the major contributor in limiting 
oxygen transport by limiting oxygen extraction [1, 3].  
As a final point, V O2max can be affected also by factors as alveolar 
ventilation/pulmonary perfusion ( V A/Q) inequality [25] and post pulmonary shunts 
[26] which are playing a small but demonstrable role in reducing arterial oxygenation 
[27].   Accordingly, in healthy subjects a limitation primarily in oxygen transport but 
also in the capacity of oxygen utilization by the working muscles constitutes important 
factors determining exercise capacity. Defects in the mechanism of oxygen transport 
and utilization also determine the magnitude of exercise intolerance in patients with 
chronic lung diseases. 
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1.3. Factors determining exercise tolerance in healthy-elderly 
individuals 
The response of the cardiovascular and respiratory systems during exercise is 
attenuated to various degrees in the elderly. Importantly, there are considerable changes 
in the connective tissue matrix of the lung that may reduce the elastic recoil pressure 
and hence the airway radial traction, thus predisposing to expiratory flow limitation and 
air trapping [28]. This justifies common clinical practice to contrast the physiological 
responses recorded in patients with lung disease with those of healthy age-matched 
individuals.  
 The limited capacity of the older adult to increase convective oxygen delivery 
and muscle oxygen utilization is due to age-related changes in cardiovascular structure 
and function [29, 30] as well as in mitochondrial content and quality [31]. These factors 
contribute to a slowed adjustment of muscle oxygen consumption and occurrence of 
premature metabolic acidosis in the older compared to the young individual [32, 33].  
In addition, ageing is accompanied by a reduction in maximal heart rate [34], left 
ventricular function [30], increased total peripheral resistance [29], diminished 
capillary density [35], endothelial dysfunction and impaired capillary haemodynamics 
[36]; all of these limitations are expected to compromise the convective oxygen 
transport to working muscles during exercise. In addition, during ageing pulmonary 
vascular stiffness, resistance and pressures are increased along with the heterogeneity 
of alveolar ventilation and pulmonary perfusion, whilst  pulmonary capillary blood 
volume and membrane diffusing capacity are decreased, thereby causing a reduction in 
alveolar-capillary surface area [37]. 
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In addition, ageing is associated with several structural and functional changes, 
related to reductions in the elastic recoil of the lung, in chest wall compliance and in 
respiratory muscle performance [38-40]. As the compliance of the lung increases and 
that of the chest wall decreases at a higher degree than that of the lung, thoracic 
expansion becomes limited; thus an older individual would have to perform ~20% more 
elastic work at a given level of minute ventilation compared to a 40-year younger fellow 
[38]. Consequently, the respiratory muscles of the older individual would be expected 
to work harder given that they are acting on a stiffer chest wall [41-43]. This would 
increase the share of cardiac output to the respiratory muscle that could potentially limit 
blood flow to the locomotor muscles [43, 44].  
Based on the above, chest wall volume regulation would be expected to differ 
among old and healthy individuals. Although a similar pattern to that described for 
healthy young adults [45, 46] has been reported in healthy older subjects, in respect of 
reducing end-expiratory chest wall volume during progressively increased exercise 
intensities [47], at peak levels of exercise end-inspiratory chest wall volume in older 
individuals often reaches ~80% of the chest wall volume at total lung capacity (TLC). 
In contrast,in healthy young subjects the ratio of end-inspiratory lung volume to TLC 
does not usually exceed  70% [43, 46]. This disparity exists because young subjects 
reduce end-expiratory chest wall volume by expiratory muscle recruitment during 
progressively increased exercise intensities, thus allowing tidal volume to expand by 
encroachment into both the inspiratory and expiratory reserve volume. In elderly, 
consequently to flow limitation at advanced levels of exercise, end-expiratory chest 
wall volume only slightly decreases, so expansion of tidal volume takes place primarily 
by encroachment on the inspiratory reserve volume (288).  Hence end-inspiratory lung 
volume reaches close to TLC with consequent increasing of the elastic work associated 
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with breathing near to TLC [47].   In the presence of significant restrictive mechanical 
constraints on tidal volume expansion, an increase in ventilatory demand with 
progressively increased exercise intensities intensifies dyspnea sensations to a greater 
degree in older compared to healthy young individuals [41, 42].   
 
1.4. Factors impairing exercise tolerance in chronic lung diseases 
Ventilatory, gas exchange, cardiovascular and peripheral muscle abnormalities 
limit exercise tolerance in patients with chronic lung diseases.  
 
1.4.1. Ventilatory constraints  
During incremental exercise, healthy elderly individuals increase minute 
ventilation by 10-15 fold; this is essential to clear the carbon dioxide production and 
suffice the increased oxygen demand [41-43, 48]. In these circumstances, ventilatory 
function does not constitute a limiting factor, at least during sub-maximal exercise, as 
minute ventilation ( V E) is maintained well below the maximum ventilatory capacity  
(MVC) [49]. Ventilatory limitation, however, occurs in healthy elderly individuals, 
particularly women [50] during maximal exercise, as the ratio of V E to MVC ( V
E/MVC) reaches or even exceeds 85%  [33, 51].  
In the majority of respiratory disorders the V E/MVC ratio often exceeds 85% 
even during submaximal exercise, commonly indicating reduced ventilatory capacity 
[48, 52].  In fact, in patients with chronic lung diseases, a disparity is developed between 
the decreased ventilatory capacity, manifested by concurrently reduced capacity to 
sufficiently increase minute ventilation during exercise and increased ventilatory 
requirement. This disparity leads to intense breathlesness that is the pivoting symptom 
limiting exercise in a substantial fraction of patients with chronic lung diseases [53, 54]. 
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The factors contributing to decreased ventilatory capacity and increased ventilatory 
requirement/workload are outlined below.   
Reduced ventilatory capacity during exercise occurs consequently to abnormal 
respiratory system mechanics and respiratory muscle dysfunction . The high inspiratory 
(and expiratory) airway resistance and/or reduced compliance may substantially 
increase airflow pressure requirements thereby increasing the work of breathing [54-
56].  
Ventilatory demand is increased during exercise secondary to gas exchange 
abnormalities (i.e.: worsening of V A/Q mismatch and increased dead space ventilation) 
leading to hypoxemia and/or hypercapnia [51]. Ventilatory requirement during exercise 
is modulated by the metabolic rate, the arterial carbon dioxide tension and the 
physiological dead space [7]. Metabolic acidosis also increases the ventilatory 
requirement of exercise [57]. Therefore,, for a given rate of CO2 output ( V CO2) and 
PaCO2, V E is usually increased because of higher dead space ventilation [1] .  
 
1.4.2. Gas exchange limitations  
Despite the deterioration in ventilatory reserve with aging, healthy older adults 
appear able to maintain alveolar ventilation at a level that allows maintenance of arterial 
blood gases within normal limits, even during heavy exercise [49, 51, 58, 59]. 
Accordingly, the ventilation-perfusion ratio ( V A/Q) remains near unity as both 
ventilation and perfusion increase several-fold with increasing exercise intensity. 
Moreover, alveolar-capillary diffusion also remains intact, and consequently PaO2 
remains normal, even during high-intensity exercise [48, 49, 51]. Furthermore, in 
healthy elderly individuals, the increase in tidal volume (VT) occurs in the setting of a 
relatively fixed anatomic dead space (VD), so that the VD/VT ratio decreases thereby 
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promoting an increase in effective alveolar ventilation as a fraction of the increased 
minute ventilation.   
In contrast, in patients with lung diseases gas exchange regulation is impaired 
during exercise. The impairment involves the airways, the pulmonary vasculature, and 
the alveolar-capillary interface, thus producing varying degrees of abnormal V A/Q 
inequalities, diffusion impairment, and hypoxemia [13, 28, 54, 60].  In fact, many 
patients with severe lung disease experience exercise-induced arterial oxygen de-
saturation. Furthermore, arterial PCO2 may be higher than in healthy subjects as VD is 
increased owing to reduced V A [61-63] .  
 
1.4.3. Central and peripheral hemodynamic factors  
Cardiac output in healthy elderly subjects increases several-fold in response to 
exercise [29, 30, 49, 51, 58].  In the majority of healthy elderly subjects, cardiac output 
is often the “rate-limiting step” to exercise, and at the limit of tolerance, heart rate 
reaches the maximal predicted. In contrast in chronic lung diseases the physiological 
mechanisms involved in oxygen transport are frequently impaired resulting in reduction 
of cardiovascular function secondary to the following reasons.  Firstly, coexisting right- 
or left-ventricular dysfunction may impair exercise function simply because of poor 
cardiac-output capability, which often compromise oxygen delivery and early 
development of metabolic acidosis. Similarly, functionally important arrhythmias may 
also impair the normal increase in cardiac output as a function of an increase in work 
rate [49, 51, 58, 64]. Secondly, in chronic lung diseases, especially in the presence of 
pulmonary vascular abnormalities, pulmonary hypertension and right-ventricular 
dysfunction may develop [65]. These phenomena may worsen in the presence of 
exercise-induced hypoxemia, which in turn elevate pulmonary vascular resistance and 
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cause pulmonary arterial hypertension with consequent right-heart failure [60, 65-71]. 
The resulting restrained increase in cardiac output during exercise, coupled with 
hypoxemia, reduces systemic oxygen delivery to the locomotor skeletal muscles. 
Interestingly, there are suggestions that as the work of breathing is often substantially 
increased in chronic lung diseases during exercise, there might exist a respiratory 
muscle “steal” of blood flow away from the locomotor muscles, which further 
compromises peripheral muscle oxygen availability [44, 72].  
 
1.4.4. Skeletal muscle abnormalities  
Chronic Respiratory diseases lead to progressively reduced levels of daily 
activity, chronic under-loading of the locomotor muscles and weakness, which is 
associated with reduced muscle mass and altered muscle fibre distribution especially 
with reference to the proportion of type-I (slow-twitch oxidative) fibres [73-79]. 
Reduction in the proportion of the oxidative fibres compromises the oxidative potential 
of the muscles and makes these muscles more prone to fatigue during high-intensity 
exercise. Furthermore, capillary density is also diminished which further reduces 
regional muscle blood flow and oxygen delivery. Such structural and metabolic 
abnormalities of the limb muscles may lead to premature metabolic acidosis acidosis 
and task failure with exercise [73-77].  
 
2.0 Cardiopulmonary Exercise Testing (CPET) 
Cardiopulmonary exercise testing is often applied in clinical practice to investigate the 
mechanisms responsible for the limitation of exercise capacity, and the extent of their 
contribution (Table 1). This test allows the concurrent study of the function of three 
organ systems: cardiovascular, respiratory and metabolic of muscle cells in well-
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controlled laboratory conditions during exercise [80]. At the same time, 
cardiopulmonary exercise testing (CPET), allows recordings of subjective factors such 
as dyspnea and muscle discomfort in conditions where symptoms are apparent or 
become more pronounced. CPET test indicated in patients with limited exercise 
capacity, when the causes of exercise limitation have not been sufficiently clarified 
following a thorough respiratory or central hemodynamic evaluation [81, 82]. 
Applications of CPET are presented in table 2. 
The most widely used types of exercise testing that are applied in the clinical evaluation 
of patients are the incremental exercise test to the limit of tolerance and the constant-
load exercise test sustained at a fraction of peak exercise capacity. More often these 
tests are conducted on an electromagnetically braked cycle ergometer [84]. 
 
 
 
 
Table 1. Mechanisms limiting exercise capacity in chronic respiratory diseases. 
1) Expiratory flow limitation 
2) Exercise-induced dynamic hyperinflation 
3) Increased work of breathing 
4) Disturbance between alveolar ventilation / perfusion ratio 
5) Impaired cardiac performance 
6) Peripheral muscle dysfunction 
 
 
Table 2. Diagnostic uses of exercise testing 
1) Myocardial ischemia 
2) Peripheral vascular disease  
3) Exercise-induced asthma 
4) Unfitness 
5) Psychogenic dyspnea 
6) Muscle phosphorylase deficiency 
 
 
2.1 Types of cardiopulmonary exercise testing  
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2.1.1 Incremental exercise 
This test subjects the patient to a gradually increase of load upon all physiological 
systems responding during exercise. The intensity gradually increases until symptoms 
of dyspnea and / or muscle discomfort limit further increase of the imposed work. This 
test allows determination of biological responses of transport and utilization of oxygen 
up to the limit of exercise tolerance (i.e. the peak oxygen uptake (VO2peak). 
Furthermore when the test is performed on a cycle ergometer, the rate of change of 
oxygen uptake (VO2) in relation to the work rate (WR) reflects the sufficiency of the 
operating physiological systems involved in the transport to and utilization of oxygen 
by the operating organs during conditions of increasing external load [80, 82, 83] 
(Figure 1). 
 
 
Figure 1. Change of the oxygen uptake in relation to work rate on a cycle ergometer 
in a healthy individual (dotted line) and in a patient with COPD (solid line). 
 
 
2.1.2 Constant-load exercise 
During constant-load exercise testing, the patient is asked to perform work that 
corresponds to a certain fraction of his/her peak exercise capacity (which typically 
ranges between 50 to 75%) to the limit of tolerance caused by intense dyspnea and/or 
muscle discomfort symptoms (Figure 2). The period of dynamic adaptation until 
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stabilization of cardiorespiratory and metabolic responses provide valuable information 
about the operation and response of the capacity of the respiratory, cardiovascular and 
metabolic systems to sufficiently respond to a given load [85, 84]. Table 3 shows the 
effect of different types of interventions during constant load exercise in patients with 
COPD [83]. 
 
Table 3. Effect of different types of interventions during constant-load exercise in 
patients with COPD. 
Type of intervention 
Medication 
(Tiotropium) 
Oxygen 
supplementatio
n 50% 
Helium (79%) 
and oxygen 
(21%) 
supplementatio
n 
Rehabilitation 
Exercise intensity, (%) 
predicted 
75 75 80 75 
Change in exercise tolerance 
time (%) 
+21 +145 +115 +224 
Change in inspiratory capacity 
(%) 
+12 +24 +12 +15 
Change in dyspnea sensation 
(%) 
-14 -40 -25 -30 
 
Besides the two aforementioned tests, there are tests that provide less information 
concerning the physiological responses, but even like this they allow the determination 
of the exercise capacity to some extent. The most widely used test is the 6 minute walk 
test, which is submaximal and is often applied to evaluate the efficacy of 
pharmaceutical or non-pharmaceutical interventions [83]. 
 
2.2 Recorded variables during cardiopulmonary exercise testing  
Peak oxygen uptake (VO2peak): The classic criterion for the determination of 
exercise capacity and cardiorespiratory efficiency is provided by recording peak 
oxygen uptake. In a well-executed incremental test, the peak oxygen uptake reflects the 
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maximum aerobic capacity. This parameter reflects the oxygen binding capacity of 
hemoglobin molecules in alveolar level, the transfer to the periphery through the 
mediation of the cardiovascular system and its utilization by mitochondria in skeletal 
muscle to produce external work. Values lower than 80% predicted are considered 
abnormal and values below 50% predicted indicate serious dysfunction of the above 
physiological systems (Table 4) [82, 83]. 
Anaerobic threshold: The anaerobic threshold (AT) is often considered as an index 
for the initiation of metabolic acidosis, which is the result of the increase of lactic acid 
in arterial blood during exercise [85]. Normal values when detecting the anaerobic 
threshold represent at least 45% to 50% of peak oxygen uptake (Table 4). 
 
 
Table 4. Values of physiological responses in a patient with COPD during incremental 
exercise testing, expressed as a fraction of the expected values in healthy individuals. 
Variable Predicted Measured 
Presentence of 
predicted (%) 
Peak oxygen uptake, VO2 peak 
(liters / minute) 
1.67 0.90 54 
Peak heart rate 
(beats / minute) 
151 136 90 
Peak work rate (Watt) 60 30 50 
Peak oxygen pulse 
(ml / beats) 
11.1 6.6 60 
Change in oxygen uptake / Change 
in work rate ΔVO2/ΔWR (ml / 
minute / watt) 
10.3 8.9 - 
Anaerobic threshold (liters / 
minute of VO2) 
1.0 0.5 50 
Peak ventilation VE (liters / 
minute) 
90 40 45 
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Oxygen pulse: It reflects the amount of oxygen extracted from the peripheral muscles 
within each heartbeat. According to the modified equation of Fick, the oxygenic pulse 
is numerically equal to the product of stroke volume (SV) and arteriovenous oxygen 
difference (C(a-v)O2), i.e. VO2/HR = SV * C(a-v)O2 and is commonly used as an index 
of stroke volume during exercise [83]. 
Breathing reserve: The degree of ventilatory limitation profoundly contributes to the 
impaired exercise capacity, and can be evaluated from the respiratory reserve, which 
reflects the relationship of respiratory requirement in relation to respiratory capacity. 
For most healthy adults, the maximum pulmonary ventilation (VE) during exercise does 
not exceed 70% of maximum voluntary ventilation (MVV), although this fraction may 
increase (VE/MVV> 0.75) indicating limited respiratory reserve in chronic 
cardiorespiratory diseases [80, 82, 83]. 
 
2.3 Pathophysiological manifestations  
2.3.1 Chronic Obstructive Pulmonary Disease (COPD) 
Reduced exercise capacity in patients with COPD is usually manifested by reduced 
peak oxygen uptake (Figure 3A), and early onset of the anaerobic threshold, which 
reflects early metabolic acidosis. The premature termination of exercise testing is 
accompanied by additional low value of peak pulmonary ventilation (VE) (Figure 3B), 
and by breathlessness (Figure 3C) and muscle discomfort [80]. 
It is well documented that exercise tolerance during constant-load testing on a cycle 
ergometer largely depends on the imposing load, as the time to the limit of tolerance in 
patients with COPD decreases proportionally to increasing power output. Studies have 
shown that the rate of change in oxygen uptake during the transitional phase from 
unloading cycling to constant-load exercise is faster in healthy individuals 
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(approximately 35 sec) compared to patients with COPD (approximately 75sec) [85] 
(Figure 2). The slower kinetic response of oxygen uptake is considered to lead to an 
early and greater reliance on anaerobic metabolism causing the accumulation of by-
products of metabolism accelerating the onset of muscle fatigue [85]. 
 
 
Figure 2. Changes in oxygen uptake during the transition from unloading exercise to 
constant-load exercise in a healthy man (dotted line) and in a patient with COPD (solid 
line). 
 
 
2.3.2 Interstitial Lung Disease 
During cardiopulmonary exercise testing, the peak values of work rate and oxygen 
uptake (Figure 3A), the oxygen tension in the arterial blood (Figure 3D), and the 
respiratory reserve are all reduced in patients with interstitial lung disease, compared to 
healthy individuals. For given oxygen consumption the rate of increase of pulmonary 
ventilation (VE) is disproportionately increased compared to healthy age-matched 
individuals (Figure 3B). At peak exercise tolerance a significant heart rate reserve is 
observed as peak heart rate is reduced. 
During constant-load exercise, patients with interstitial lung disease have increased 
pulmonary ventilation (VE), for a given load or a given oxygen consumption, and 
increased values of the produced carbon dioxide output (VCO2) due to increased dead 
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space ventilation. In these patients, the ratio between minute ventilation to oxygen 
uptake (VO2) and the produced carbon dioxide (VCO2) is abnormally high. The 
occurrence of arterial hypoxemia during cardiopulmonary exercise testing is commonly 
associated with an unusually broad arteriovenous oxygen difference and reduced tissue 
oxygenation. These factors play an important role in the early onset of metabolic 
acidosis during submaximal exercise. Thus, limitation of exercise tolerance is often due 
to symptoms of both dyspnea and discomfort of the lower limbs [80, 82, 83]. 
 
          
        
Figure 3. Responses of A: oxygen uptake, B: pulmonary ventilation, C: dyspnea 
sensations and D: oxygen tension in the arterial blood during cardiopulmonary exercise 
testing in patients with COPD (triangles) with pulmonary hypertension (squares), with 
C 
D 
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interstitial lung diseases (circles) compared with healthy age-matched individuals 
(dotted lines). [80] 
 
2.3.3 Pulmonary Hypertension 
During cardiopulmonary exercise testing, peak values of oxygen uptake (VO2) (Figure 
3A) and of work rate are reduced in patients with pulmonary hypertension compared to 
healthy age-matched. However, the slope of the relationship of the oxygen uptake over 
the work rate is normal (Figure 3A). At peak exercise tolerance heart rate reaches the 
maximum predicted value, whilst pulmonary ventilation exceeds 85% of maximum 
voluntary ventilation (Figure 3B), thus exercise in these patients is often limited by both 
cardiovascular and respiratory factors [80, 83]. 
During submaximal exercise these patients exhibit tachycardia due to increased 
pulmonary vascular resistance and the consequent increase in the afterload of the right 
ventricle, which limits the increase in stroke volume. On the other hand, excessive 
enlargement of arteriovenous oxygen tension and an unusually high ratio between 
pulmonary ventilation and carbon dioxide output, implies an increase of dead space 
ventilation due to the high heterogeneity between alveolar ventilation and blood flow 
(VA/Q) causing severe hypoxemia (Figure 3D). Such a model of cardiopulmonary 
disorder promotes early onset of metabolic acidosis, limits the quantity of readily 
available oxygen to peripheral muscles, thereby causing premature occurrence of 
peripheral muscle fatigue [80, 82, 83]. 
 
3.0 CPET: a tool for predicting mortality 
Cardiopulmonary exercise testing emerges as a useful tool for the prognosis of 
mortality in patients with lung diseases. Peak oxygen intake is the most important 
predictor of mortality rate at a depth of 5 years in patients with Chronic Obstructive 
Pulmonary Disease and is a significant predictor of survival in patients with pulmonary 
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hypertension [82, 83]. In patients with interstitial lung disease, cardiopulmonary 
exercise testing has proved particularly useful in predicting the prognosis of the disease. 
The peak oxygen consumption, oxygen consumption corresponding to the anaerobic 
threshold, and the slope of change in pulmonary ventilation over carbon dioxide output 
are useful predictors of patient survival with chronic respiratory diseases, however, a 
wider range of factors are also playing an important role in the survival of these patients 
and thus they should be taken into account [81, 83, 84]. 
 
4.0 CPET: a tool for evaluating exertional dyspnoea 
Why is cardiopulmonary exercise testing (CPET) an important tool for exploring 
exertional dyspnoea ("dyspnoea which occurs during exercise”) both in research and 
clinical settings? For several reasons: 1) CPET may help researchers and clinicians  
explore and unmask the physiological mechanisms (interaction between them) 
underlying this symptom in a broad spectrum of cardio-respiratory disorders; 2) CPET 
may also help clinicians identify additional mechanisms underpinning the greater 
dyspnoea intensity which could stand as “independent of” or “not directly related to” 
the main/obvious pathophysiological determinant of the disease under consideration; 
CPET may also be utilised to explore the mechanisms by which exertional dyspnoea 
can be altered (ameliorated) after pharmacological and non-pharmacological 
interventions. 
Why is exertional dyspnoea worth documenting and accurately assessing? For at least 
the following reasons: 1) activity-related dyspnoea is usually the earliest and most 
troublesome complaint for which patients with cardio-pulmonary diseases seek medical 
attention; 2) this symptom progresses relentlessly as the underlying disease advances 
leading invariably to avoidance of activity with consequent skeletal muscle 
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deconditioning and an impoverished quality of life; 3) up to a quarter of the general 
population and half of severely ill patients are affected by this symptom; 4) dyspnoea 
is also an important predictor of quality of life, exercise tolerance and mortality in 
various conditions. In patients with chronic obstructive pulmonary disease (COPD), 
dyspnoea has been found to be a better predictor of mortality than forced expiratory 
volume in 1 s (FEV1). In patients with heart disease referred for clinical exercise 
testing, it is a better predictor of mortality than angina; 5) dyspnoea is also associated 
with decreased functional status and worse psychological health in older individuals 
living at home; 6) it is also a factor in the low adherence to exercise training 
programmes in sedentary adults and in patients with COPD; 7) the effective 
management of exertional dyspnoea remains a major challenge for caregivers, and 
modern treatment strategies that are based on attempts to reverse the underlying chronic 
condition are only partially successful [85-91]. 
Two recent review articles [85, 92] have explored and clarified in greater details the 
physiological mechanisms underlying exertional dyspnoea and their applications in 
reaserach and clinical practice.  
Dyspnoea is a complex, multifaceted, highly personalised and multidimensional 
symptom comprising three major dimensions (the sensory-perceptual domain, the 
affective distress, and the symptom impact or burden), the perception of which involves 
the integration of afferent and efferent inputs at cortical level and is modulated by 
affective/emotional/behavioural components, as recently stated by the American 
Thoracic Society [93] and European Respiratory Society [85]. 
There is no unique central or peripheral source of this symptom. The definition given 
by the latest ATS statement (a subjective experience of breathing discomfort that 
consists of qualitatively distinct sensations that vary in intensity) highlights the 
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importance of the different qualities (descriptors) covered by the term dyspnoea, the 
cortical integration of multiple sources of neural inputs about breathing and the 
physiological affective and behavioral consequences [93]. Dyspnoea is believed  to 
arise when there is a conscious awareness of dissociation between what the brain 
expects (through the "corollary discharge", i.e., copy of the descending motor activity 
to perceptual areas) and what it receives in terms of neural inputs from the respiratory 
system, respiratory muscles, peripheral chemoreceptors and locomotor muscles [93]. It 
goes without saying that  not all conscious breathing sensations can be labelled as 
“dyspnoea” because the brain is able to “filter” all the respiratory sensations and let 
only some of them reach the conscious level [85]. This sensory gating process hinders 
the brain from being constantly overloaded by irrelevant sensory information. Human 
beings have the voluntary capacity to bring “breathing” into awareness at any moment. 
On the other hand, breathing may come to conscious awareness automatically if it needs 
to be attended to (gate-in). This “gating process” is instrumental in monitoring essential 
biological and physiological functions and adopting appropriate behaviour. It has been 
proposed that respiratory sensations are the result of neural gating into the cerebral 
cortex of respiratory afferent input eliciting a somatosensory cognitive awareness of 
breathing and an affective response [85]. 
For a pedagogic purpose we can summarise in a very simplistic way that dyspnoea may 
stem from two processes: 1) a discriminative one which identifies relevant afferent 
information on respiratory disruption/abnormalities and brings them to consciousness 
(sensory components: intensity and quality); and 2) an affective one which labels the 
now conscious sensation as unpleasant or threatening, i.e. dyspnoea. 
Dyspnoea is not a single sensation, and our brain is able to distinguish among different 
afferent information and give each of them a distinct cognitive sensation, notably: 1) 
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work/effort (‘‘breathing requires work or effort’’); 2) tightness (‘‘chest is constricted, 
chest feels tight’’); and 3) air hunger (‘‘unsatisfied inspiration, starved for air, urge to 
breathe, like breath holding’’). It is generally accepted that these sensations do not share 
the same physiological mechanisms [85, 93]. Some of these sensations, such as 
work/effort and air hunger may exist and vary independently in the same subject or 
experimental condition. Notwithstanding, whether there are multiple types of dyspnoea, 
whether they are subjective expression of different neurophysiological mechanisms or 
the same neurophysiological mechanisms may be expressed differently in relation to 
language, psychological, cultural,  and/or social context) is at the moment unclear and 
required additional research. 
Can dyspnoea  also be quantified (“intensity”). Yes, exertional dyspnoea can be easily 
defined as "the perception of respiratory discomfort that occurs for an activity level that 
does not normally lead to breathing discomfort". It follows that the intensity of 
dyspnoea can be determined by assessing the activity level required to produce 
dyspnoea (i.e. dyspnoea at rest is more severe than dyspnoea when climbing stairs) 
[85]. Dyspnoea can therefore be  assessed during a physical task, such as CPET [85, 
93]. For this purpose, the 10-point Borg scale can be used to rate a specific respiratory 
sensation (e.g., inspiratory difficulty, breathing effort, expiratory difficulty, air hunger, 
etc.) or a more general one (e.g., breathing difficulty, breathlessness). The magnitude 
of respiratory sensation is anchored at both extremes of the scale such that a rating of 
“0” represents no breathing discomfort and “10” represents the maximal breathlessness 
that the subject had ever experienced or could imagine experiencing. The visual 
analogue scale (VAS) is another dyspnoea measuring instrument with proven construct 
validity used during CPET. Both the VAS and Borg scale have been shown to provide 
similar scores during CPET, and to be reliable and reproducible over time in healthy 
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subjects, and in patients with chronic respiratory diseases undergoing CPET [84]. The 
advantage of using the Borg or VAS scales in individual patients is the possibility of 
reliably comparing “intensity of exertional dyspnoea” at the same level of exercise 
activity (standardised work-rate or oxygen consumption or ventilation during CPET) 
between subjects, and before and after a pharmacological and/or non-pharmacological 
treatment [84]. Studies in cardiopulmonary diseases have shown that during CPET 
there is a close correlation between the magnitude (and duration) of respiratory effort 
(measured by tidal oesophageal pressure relative to maximum) and the intensity of 
dyspnoea (measured by the Borg scale), and that pharmacological manipulations able 
to reduce the magnitude (and duration) of respiratory effort are clearly and consistently 
associated with reduced dyspnoea intensity [84, 85]. 
The interest of using CPET in this setting is also that quality and quantity of dyspnoea 
can  be measured together during CPET. Few studies have shown that moderate-to-
severe chronic obstructive pulmonary disease (COPD) and even mild stable asthmatics 
are able to “perceive” dynamic changes in their mechanics of breathing during exercise: 
once a critical inspiratory reserve volume (IRV) is attained (0.3-0.5L from total lung 
capacity), tidal volume expansion is critically constrained, dyspnoea intensity rises 
abruptly and there is a transition in the dominant qualitative descriptor choice from 
work/effort to difficult/unsatisfied inspiration [85]. The clinical relevance of these 
findings is that by asking the quality of dyspnoea at the end of an exercise bout one can 
ascertain whether a critical IRV (difficult/unsatisfied inspiration) or not (work/effort) 
has been reached, i.e., the likelihood of developing exercise-related critical volume 
constraints [85]. Exertional dyspnoea is by far the dominant symptom in patients with 
Pulmonary Arterial Hypertension (PAH) [94-96]. Recent advances in PAH have 
highlighted the importance of respiratory mechanical anomalies easily detectable 
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during CPET in contributing to exertional dyspnoea in PAH patients; some of them (up 
to 60%) may exhibit reduced expiratory flows in tidal operating range, which could 
promote exercise-induced dynamic lung hyperinflation, and this can be a major source 
of dyspnoea on exertion also in this population [94]. Although exertional dyspnoea in 
these patients is likely multifactorial, the increased ventilatory demand and abnormal 
dynamic ventilatory mechanics need be considered in PAH  patients [94], in the absence 
of respiratory muscle dysfunction [96] or TLC changes [94]. 
CPET can also be used to evaluate mechanisms of exertional dyspnoea in chronic heart 
failure. Heart failure patients may report dyspnoea alone or in variable combination 
with leg discomfort as the exercise limiting symptoms. In heart failure no hemodynamic 
and respiratory variables, either at rest or during exercise, seem to be able to 
discriminate between heart failure patients who complain of dyspnoea as the 
predominant exercise limiting symptom from those who report leg discomfort. Clearly 
the issue is still unsolved and more studies are needed [85]. 
We hope we have convinced the reader of the crucial importance of using CPET for the 
global evaluation of exercise tolerance as well as for evaluating the physiological 
mechanisms underlying the perception of exertional dyspnoea that can be amenable to 
therapeutic interventions.  
 
 
5.0 Conclusions 
Functional measurements at rest do not always provide an accurate diagnosis and a 
proper stratification of severity in patients with chronic respiratory diseases. 
Cardiopulmonary exercise testing complimentary applied to functional tests at rest, 
provides useful information on exercise capacity and a comprehensive evaluation of the 
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biological and phisiological mechanisms that limit exercise tolerance and underpin 
exertional dyspnoea in all cardiorespiratory disorders. 
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